{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:03:30Z","timestamp":1786719810499,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001794","name":"The University of Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Mutations in the\n                      <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                      (NG)\n                      <jats:italic>gyrA<\/jats:italic>\n                      codons 91 and 95 are known to confer resistance to ciprofloxacin, but questions remain over whether all the various permutations of these codons are needed for optimal molecular detection of NG ciprofloxacin susceptibility. Here, we used publicly available sequence data to answer this question to help inform the design of next-generation NG\n                      <jats:italic>gyrA<\/jats:italic>\n                      assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      NG\n                      <jats:italic>gyrA<\/jats:italic>\n                      alleles (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200973) were downloaded from the NG-STAR platform, as were all NG sequences and associated metadata from Pathogenwatch (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200938,367 records;\n                      <jats:italic>n=<\/jats:italic>\n                      31,114 following de-duplication). Analyses focused on understanding the frequency of NG\n                      <jats:italic>gyrA<\/jats:italic>\n                      91 and 95 alterations and the applicability of assay designs to detect ciprofloxacin resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      While the 73 NG-STAR alleles reflect considerable\n                      <jats:italic>gyrA<\/jats:italic>\n                      sequence diversity, just four amino acid combinations at codons 91 and 95 (wild-type; S91F\/D95A; S91F\/D95G; S91F\/D95N) comprised\u2009&gt;\u200999% of isolates. Also, 91-only and 95-only mutants are rare, comprising less than 1% of sequences, and moreover were typically sporadic temporally and genetically (e.g., within and across different MLSTs). The results also indicate that certain NG-STAR alleles (e.g.,\n                      <jats:italic>gyrA_42.0<\/jats:italic>\n                      ,\n                      <jats:italic>gyrA_53.0<\/jats:italic>\n                      , and\n                      <jats:italic>gyrA_60.0<\/jats:italic>\n                      ) have high sequence homology with other commensals, including\n                      <jats:italic>Neisseria meningitidis<\/jats:italic>\n                      , and hence warrant careful consideration during assay design to avoid off-target detection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The results highlight that 91-only and 95-only mutants do occur at relatively low frequency, and hence assays should\n                      <jats:italic>ideally<\/jats:italic>\n                      detect both SNPs\n                      <jats:italic>independently<\/jats:italic>\n                      , with 91 as the priority. However, an assay targeting either codon alone, or both codons collectively without independently discriminating each codon, would still correctly classify approximately 99% of resistant alleles. The 0.47% of single-codon mutants, if not accounted for by an assay, nonetheless carry a real, if small, risk of false-susceptible results at the individual patient level. Local validation against contemporary sequence diversity, ideally integrated with the European Centre for Disease Prevention and Control (ECDC) Euro-GASP framework, remains essential for any assay design and deployment decision.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-026-05628-9","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:23:01Z","timestamp":1786717381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequence analyses to accelerate the development of rapid resistance assays targeting the Neisseria gonorrhoeae gyrA gene"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0491-4232","authenticated-orcid":false,"given":"Abdulrahman K. S.","family":"Ayfan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-3161","authenticated-orcid":false,"given":"David M.","family":"Whiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-0564","authenticated-orcid":false,"given":"Leah W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"5628_CR1","unstructured":"World Health Organization, Gonorrhoea (Neisseria gonorrhoeae infection) (2024) Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/gonorrhoea-(neisseria-gonorrhoeae-infection)"},{"issue":"9","key":"5628_CR2","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1016\/S1473-3099(24)00486-9","volume":"24","author":"SJ van Hal","year":"2024","unstructured":"van Hal SJ et al (2024) Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone. Lancet Infect Dis 24(9):e547\u2013e548. https:\/\/doi.org\/10.1016\/S1473-3099(24)00486-9","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5628_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3201\/eid3008.240139","volume":"30","author":"L Xiu","year":"2024","unstructured":"Xiu L, Zhang L, Peng J (2024) Surge in Ceftriaxone-Resistant Neisseria gonorrhoeae FC428-Like Strains, Asia-Pacific Region, 2015\u20132022. Emerg Infect Dis 30(8):1683\u20131686. https:\/\/doi.org\/10.3201\/eid3008.240139","journal-title":"Emerg Infect Dis"},{"key":"5628_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nature.2017.22270","author":"A Maxmen","year":"2017","unstructured":"Maxmen A (2017) Untreatable gonorrhoea on the rise worldwide. Nature. https:\/\/doi.org\/10.1038\/nature.2017.22270","journal-title":"Nature"},{"issue":"4","key":"5628_CR5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/jac\/dkv432","volume":"71","author":"MJ Pond","year":"2016","unstructured":"Pond MJ et al (2016) Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy. J Antimicrob Chemother 71(4):897\u2013902. https:\/\/doi.org\/10.1093\/jac\/dkv432","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5628_CR6","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S1473-3099(22)00520-5","volume":"22","author":"JA Tickner","year":"2022","unstructured":"Tickner JA, Lahra MM, Whiley DM (2022) The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae. Lancet Infect Dis 22(9):1271\u20131272. https:\/\/doi.org\/10.1016\/S1473-3099(22)00520-5","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5628_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01039-23","volume":"62","author":"TM Pryce","year":"2024","unstructured":"Pryce TM et al (2024) Maximizing the Neisseria gonorrhoeae confirmatory rate and the genotypic detection of ciprofloxacin resistance for samples screened with cobas CT\/NG. J Clin Microbiol 62(1):e01039-23. https:\/\/doi.org\/10.1128\/jcm.01039-23","journal-title":"J Clin Microbiol"},{"issue":"11","key":"5628_CR8","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/jac\/dkac242","volume":"77","author":"AKS Ayfan","year":"2022","unstructured":"Ayfan AKS et al (2022) Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility. J Antimicrob Chemother 77(11):2933\u20132936. https:\/\/doi.org\/10.1093\/jac\/dkac242","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5628_CR9","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1016\/S2666-5247(22)00356-1","volume":"4","author":"DH Rubin","year":"2023","unstructured":"Rubin DH, Mortimer TD, Grad YH (2023) Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study. Lancet Microbe 4(4):e247\u2013e254. https:\/\/doi.org\/10.1016\/S2666-5247(22)00356-1","journal-title":"Lancet Microbe"},{"issue":"7","key":"5628_CR10","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/jac\/dkx067","volume":"72","author":"DW Eyre","year":"2017","unstructured":"Eyre DW et al (2017) WGS to predict antibiotic MICs for Neisseria gonorrhoeae. J Antimicrob Chemother 72(7):1937\u20131947. https:\/\/doi.org\/10.1093\/jac\/dkx067","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5628_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/jac\/dkv366","volume":"71","author":"C Buckley","year":"2016","unstructured":"Buckley C et al (2016) A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility. J Antimicrob Chemother 71(2):353\u2013356. https:\/\/doi.org\/10.1093\/jac\/dkv366","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5628_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S1473-3099(16)30271-7","volume":"16","author":"E Trembizki","year":"2016","unstructured":"Trembizki E et al (2016) Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin. Lancet Infect Dis 16(9):1005\u20131006. https:\/\/doi.org\/10.1016\/S1473-3099(16)30271-7","journal-title":"Lancet Infect Dis"},{"key":"5628_CR13","unstructured":"Government of Canada NG-STAR (Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance). Available from: https:\/\/ngstar.canada.ca\/"},{"key":"5628_CR14","unstructured":"Pathogenwatch Centre for Genomic Pathogen Surveillance. Available from: https:\/\/pathogen.watch\/"},{"issue":"1","key":"5628_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12866-019-1439-1","volume":"19","author":"MW Kivata","year":"2019","unstructured":"Kivata MW et al (2019) gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya. BMC Microbiol 19(1):76. https:\/\/doi.org\/10.1186\/s12866-019-1439-1","journal-title":"BMC Microbiol"},{"key":"5628_CR16","doi-asserted-by":"publisher","unstructured":"McKinney W (2010) Data Structures for Statistical Computing in Python. Proc 9th Python Sci Conf 56\u201361. https:\/\/doi.org\/10.25080\/Majora-92bf1922-00a","DOI":"10.25080\/Majora-92bf1922-00a"},{"issue":"7825","key":"5628_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris CR et al (2020) Array programming with NumPy. Nature 585(7825):357\u2013362. https:\/\/doi.org\/10.1038\/s41586-020-2649-2","journal-title":"Nature"},{"issue":"3","key":"5628_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: A 2D graphics environment. Comput Sci Eng 9(3):90\u201395. https:\/\/doi.org\/10.1109\/MCSE.2007.55","journal-title":"Comput Sci Eng"},{"issue":"2","key":"5628_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/cid\/ciaa596","volume":"73","author":"JD Klausner","year":"2021","unstructured":"Klausner JD et al (2021) Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study. Clin Infect Dis 73(2):298\u2013303. https:\/\/doi.org\/10.1093\/cid\/ciaa596","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5628_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/sextrans-2023-056099","volume":"100","author":"E Goldstein","year":"2024","unstructured":"Goldstein E et al (2024) Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic. Sex Transm Infect 100(4):226\u2013230. https:\/\/doi.org\/10.1136\/sextrans-2023-056099","journal-title":"Sex Transm Infect"},{"key":"5628_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000002340","author":"SE McLaughlin","year":"2026","unstructured":"McLaughlin SE et al (2026) Implementation, feasibility and acceptability of reflex molecular antibiotic resistance testing for treatment diversification of N. gonorrhoeae in a sexual health clinic. Sex Transm Dis. https:\/\/doi.org\/10.1097\/OLQ.0000000000002340","journal-title":"Sex Transm Dis"},{"issue":"7","key":"5628_CR22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/infdis\/jiad027","volume":"227","author":"CC Bristow","year":"2023","unstructured":"Bristow CC et al (2023) Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae. J Infect Dis 227(7):917\u2013925. https:\/\/doi.org\/10.1093\/infdis\/jiad027","journal-title":"J Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05628-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:23:04Z","timestamp":1786717384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05628-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":22,"alternative-id":["5628"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05628-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is an observational study. The University of Queensland Research Ethics Committee has confirmed that no ethical approval is required.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. No Informed consent is required.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. No consent is required.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DMW reports research funding from SpeeDx Pty Ltd. All other authors: none to declare.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}